Dutasteride/tamsulosin

Deleobuvir (BI-207127)

Deruxtecan-d4 is deuterium labeled Deruxtecan. Deruxtecan is an ADC drug-linker conjugate composed of an DX-8951 derivative (DXd) and a maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.In vitro research MCE has not

Deruxtecan-d4-1 is the deuterium labeled Adenosine 5'-monophosphate disodium salt

Desvenlafaxine

Diisobutyl thiuram disulfide

Evacuation Traps, 2-1/4, 144/bx";MPN=UBC-85502"

Evacuation Traps, 2-3/4, 144/bx";MPN=UBC-85512"

Evacuation Traps, 1-1/4, 144/bx";MPN=UBC-85500"

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Biochem/physiol Actions Dynarrestin is a potent and selective reversible inhibitor of cytoplasmic dyneins 1 and 2 that inhibits dynein 1-dependent microtubule binding and motility without affecting ATP hydrolysis. It inhibits endosome movement and

A cell-permeable, reversible inhibitor of dynamin 1, dynamin 2, and mitochondrial dynamin, Drp1 GTPase activity (IC₅₀ = 15 &muM) inhibits clathrin-dependent vesicle formation and endocytosis can also augment the release of

A cell-permeable, reversible inhibitor of dynamin 1, dynamin 2, and mitochondrial dynamin, Drp1 GTPase activity (IC₅₀ = 15 &muM) inhibits clathrin-dependent vesicle formation and endocytosis can also augment the release of